119 results
8-K
EX-10.1
PVCT
Provectus Biopharmaceuticals, Inc.
27 Mar 24
Entry into a Material Definitive Agreement
12:10pm
;
direct research and development expenses incurred by LICENSEE and required to be incurred by LICENSEE under the sublicense;
debt on arm’s length terms … party (other than routine research and development agreements, such as agreements with contract research organizations), within five (5) days following
8-K
EX-10.2
PVCT
Provectus Biopharmaceuticals, Inc.
26 Mar 24
Departure of Directors or Certain Officers
4:48pm
information, marketing information, research and development efforts, production, sales, technologies, finances and financial controls, legal